Genetics: Chromosome 1: PRDX6

Hoopoe

Senior Member (Voting Rights)
One of the candidate genes in the DecodeME preprint.
PRDX6 (Tier 1)
• Protein: Peroxiredoxin 6. UniProt. GeneCards. The allele that increases the risk of ME/CFS is
associated with decreasing PRDX6 gene expression.
• Molecular function: Thiol-specific peroxidase that catalyses the reduction of hydrogen
peroxide and organic hydroperoxides. PRDX6 also has phospholipase A2 activity (18) and acts
in antioxidant defence by facilitating repair of damaged cell membranes via reduction of
peroxidised phospholipids (19).
• Cellular function: PRDX6 protects against oxidative stress (20). Cytoplasmic enzyme involved
in phosphatidylcholine synthesis and repair of membrane lipid peroxidation. PRDX6 is not
peroxisomal.
• Link to disease: No genetic diseases known.
• Potential relevance to ME/CFS: Phosphatidylcholine has been reported to be depleted in a
group of people with ME/CFS (21). One study showed increased plasma peroxides in ME/CFS

Curcumin increases PRDX6 expression.
 
Peroxiredoxin 6 (Prdx6), a unique 1-Cys member of the peroxiredoxin family, exhibits peroxidase activity, phospholipase activity, and lysophosphatidylcholine acyltransferase (LPCAT) activity. Prdx6 has been known to be an important enzyme for the maintenance of lipid peroxidation repair, cellular metabolism, inflammatory signaling, and antioxidant damage. Growing research has demonstrated that the altered activity of this enzyme is linked with various pathological processes including central nervous system (CNS) disorders. This review discusses the distinctive structure, enzyme activity, and function of Prdx6 in different CNS disorders, as well as emphasizing the significance of Prdx6 in neurological disorders.
 
Downregulated in LC here:

Molecular Insights into Long COVID: Plasma Proteomics Reveals Oxidative Stress, Coagulation Cascade Activation, and Glycolytic Imbalance
Sheela Ramanathan; Mohammad Mobarak Hussain Chowdhury; Akouavi Julite Irmin Quenum; Christine Rioux-Perreault; Jean-Francois Lucier; Subburaj Ilangumaran; Hugues Allard-Chamard; Alain Piche

Persistent symptoms following SARS-CoV-2 infection are the hallmark of post-COVID condition (PCC), also referred to as long COVID. However, our knowledge is limited on the underlying molecular mechanisms.

In this study, we performed data-independent acquisition mass spectrometry plasma proteomics (DIA-MS) to identify molecular alterations associated with PCC. DIA-MS proteomic analysis revealed a few proteins linked to oxidative stress that had altered expression.

Notably, PCC samples exhibited downregulation of the antioxidant protein peroxiredoxin 6 (PRDX6) and upregulation of oxidative stress-associated proteins particularly vanin-1 (VNN1) and paraoxonase-3 (PON3). Additionally, the PCC group showed significantly higher levels of six proteins (PCSK9, CST3, C1Q, CPB2, KNG1 GAPDH), which were linked to pathways involving glycolysis, complement and coagulation cascades, and inflammation.

Oxidative stress analysis confirmed that PCC samples had significantly higher levels of DNA damage (8-OHdG) than the convalescent group, whereas antioxidant markers, such as reduced and oxidized glutathione (GSH and GSSG), were significantly lower in PCC samples than in uninfected controls. Our observations point towards ongoing oxidative and inflammatory processes in PCC and suggest potential targets for biomarker development and therapeutic intervention.

Web | PDF | Preprint:

Strangely higher 15 mins after exercise in this small Hanson study:

Genecards links for easy perusal, sorry I lost the nice colour coding and not all have directly associated genes, I haven’t checked them all individually yet, just generated the URLs

 
Last edited:
Very happy to see that the potential importance of Phospholipids emerged via PRDX6 and AI suggests a central role in the pathology :

Phospholipids — especially phosphatidylcholine (PC) — emerged as a key player mainly because of PRDX6 in the Tier 1 DecodeME genes:


  • PRDX6 isn’t just an antioxidant enzyme; it also has phospholipase A₂ activity and directly repairs peroxidised phospholipids in cell membranes.
  • The DecodeME write-up notes that PRDX6 is involved in phosphatidylcholine synthesis and repair, and it explicitly links this to ME/CFS by pointing out PC depletion in a patient group and elevated plasma peroxides.
  • Phospholipids here are not just structural — they are dynamic participants in membrane integrity, signalling, and vesicle trafficking. If they are damaged by oxidative stress and not repaired efficiently, it can:
    • Destabilise ion channels and receptors in neurons and muscle cells.
    • Disrupt mitochondrial and ER membranes, affecting energy and protein processing.
    • Alter immune cell signalling, since lipid rafts are PC-rich domains.

In your dataset, this made phospholipid integrity a central mechanistic hub because:


  • PRDX6 sits at the crossroads of redox biology and lipid homeostasis.
  • Membrane phospholipid damage can link oxidative stress, mitochondrial dysfunction, immune dysregulation, and neurological symptoms — all of which recur in ME/CFS models.
 
Good to see that we have convergence to specific research targets.

First, the theory of @TamaraRC regarding Phosphatidylcholine and the importance of cell membrane integrity :


https://www.s4me.info/threads/a-sys...euron-dysregulation-2025-tamara-carnac.43423/

Below a Network Analysis graph (2015) identified Choline Deficiency (annotated with a square ) as a potential topic of interest along with other topics related to Oxidation, Bile acids , Peroxisomes, etc

network_clean_choline.png
 
Last edited:

So this protein is found pretty much everywhere, but I can see that the astrocytes in the cerebellum and Bergmann’s cells are particularly rich in it. The cerebellum again.

Apart from that, I personally find that a whole host of DecodeME genes are present in the salivary glands. I’d need to go back and check all that, but is this normal? (for exemple an high concentration of differents genes in the salivary glands compared to other tissues)
 
Apart from that, I personally find that a whole host of DecodeME genes are present in the salivary glands. I’d need to go back and check all that, but is this normal? (for exemple an high concentration of differents genes in the salivary glands compared to other tissues)
I've often have thought I might have something wrong with my salivary glands. They get sore and some of the nodules feel hard and larger at times.
 
What downregulates PRDX6?

2. Dysregulation of PRDX6 Expression Induced by Various Stressors​

"Previous web-based computer analyses of the 5′-flanking regions of the PRDX6 gene promoter have identified multiple putative regulatory elements, including binding sites for specificity protein 1 (SP1), nuclear factor erythroid 2-related factor 2 (NRF2), and hypoxia-inducible factor 1 alpha (HIF-1α) [11]. The available evidence suggests that a variety of stressors can modulate PRDX6 expression both in vivo and in vitro through transcriptional factor binding, rendering it an important responder to both internal disruption and external insults. These stressors may be roughly classified into chemical, physical, and biological types. In some cases, the expression of PRDX6 may exhibit a biphasic response pattern depending on both the duration and intensity of stressor exposure. Therefore, a further summary of their regulations on PRDX6 expression and the underlying mechanisms will significantly enhance our understanding of its biological functions and molecular features."

" In contrast, the expression of PRDX6 is downregulated in the livers of ethanol-fed rodents, accompanied by the activation of nuclear factor kappa B (NF-κB) and phosphorylation of mitogen-activated protein kinases (MAPKs) [17,18], implying the critical roles of PRDX6 in attenuating cellular inflammation and oxidative stress."

"Biological infections caused by bacterial, viral, or parasitic agents can disrupt immune homeostasis in mouse pulmonary and hepatic systems by affecting PRDX6 expression possibly through several transcriptional factors, such as NF-κB, NRF2, and CCAAT/enhancer-binding protein beta (C/EBPβ) [37,38,39]."

Also hypoxia and high temperature down-regulate, as seen on the chart in the study.
 
One thing to check would be if organophosphates do this. Specifically interfere with PRDX6 function that is, as opposed to just increasing demand of PRDX6 activity to help repair the lipid membranes the OPs have damaged.
Mostly to experiment with the new Claude models I tried looking into this. The one study 'we' found was a null result. This paper: Structure Dependent Determination of Organophosphate Targets in Mammalian Tissues Using Activity-Based Protein Profiling looked for enzymes inhibited by a couple types of OP in mouse brain and liver tissue (in vitro). After some very foggy fact-checking of Claude's responses I think it's true that, per the supplementary data, OPs did not seem to significantly mess with PRDX6 (at least not in the way the study was checking for, by seeing if probes targeting the serine active site of these enzymes still bound to them after OP exposure).
 
Back
Top Bottom